GSK Sees Emerging Market Opportunity In Thinking Locally, Developing Locally

SINGAPORE - GSK APJEM R&D is pretty hefty as far as acronyms go, but GlaxoSmithKline's Judith Hills wants to make sure observers do not over look the research and development title in the new GSK division